Streptococcus pyogenes infect ion in mice

Microbial Pathogenesis

Volumn 20, Issue 4, 1996, Pages 213-224

  Husmann, Linda K ^a   Dillehay, Dirck L ^a,b   Jennings, Veronica M ^a,b   Scott, June R ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

Animal model; Bronchopneumonia; Mice; Pathogenesis; Pneumonia; Streptococcus group A; Streptococcus pyogenes

Indexed keywords

ANIMALIA; STREPTOCOCCUS GROUP A; STREPTOCOCCUS PYOGENES;

VIRULENCE FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL PNEUMONIA; BACTERIAL VIRULENCE; BRONCHOPNEUMONIA; CONTROLLED STUDY; HISTOPATHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; STREPTOCOCCUS GROUP A; STREPTOCOCCUS PYOGENES;

ANIMALS; BRONCHOPNEUMONIA; FEMALE; LUNG; MICE; MICE, INBRED C3H; NASAL MUCOSA; PNEUMONIA, BACTERIAL; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; TRACHEA;

EID: 0029979463     PISSN: 08824010     EISSN: None     Source Type: Journal    
DOI: 10.1006/mpat.1996.0020     Document Type: Article

References (37)

1. Hook EW, Wagner RR, Lancefield RC. An epizootic in Swiss mice caused by a group A streptococcus, newly designated type 50. Am J Hyg 1960; 72: 111-9.
2. Hoge CW, Schwartz B, Talkington DF, Breiman RF, MacNeill EM, Englender SJ. The changing epidemiology of invasive group A streptococcal infections and the emergence of streptococcal toxic shock-like syndrome. JAMA 1993; 269: 384-9.
3. The Working Group On Severe Streptococcal Infections. Defining the group A streptococcal toxic shock syndrome. JAMA 1993 269: 390-1.
4. Novotny W, Faden H, Mosovich L. Emergence of invasive group A streptococcal disease among young children. Clin Pediatr 1992; 31: 596-601.
5. Stevens DL, Tanner MH, Winship J et al. Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N Engl J Med 1989; 321: 1-7.
6. Raeder R, Boyle MDP. Association between expression of immunoglobulin G-binding proteins by group A streptococci and virulence in a mouse skin infection model. Infect Immun 1993; 61: 1378-84.
7. Bessen D, Fischetti VA. Synthetic peptide vaccine against mucosal colonization by group A streptococci. I. Protection against a heterologous M serotype with shared C repeat region epitopes. J Immunol 1990; 145: 1251-6.
8. Hollingshead SK, Simecka JW, Michalek SM. Role of M protein in pharyngeal colonization by group A streptococci in rats. Infect Immun 1993; 61: 2277-83.
9. Bessen D, Fischetti VA. Passive acquired mucosal immunity to group A streptococci by secretory immunoglobulin A. J Exp Med 1988; 167: 1945-50.
10. Bessen D, Fischetti VA. Influence of intranasal immunization with synthetic peptides corresponding to conserved epitopes of M protein on mucosal colonization by group A streptococci. Infect Immun 1988; 56: 2666-72.
11. Bronze M S, McKinsey DS, Beachey EH, Dale JB. Protective immunity evoked by locally administered group A streptococcal vaccines in mice. J Immunol 1988; 141: 2767-70.
12. Dale JB, Baird RW, Courtney HS et al. Passive protection of mice against group A streptococcal pharyngeal infection by lipoteichoic acid. J Infect Dis 1994; 169: 319-23.
13. Wessels MR, Bronze MS. Critical role of the group A streptococcal capsule in pharyngeal colonization and infection in mice. Proc Natl Acad Sci USA 1994; 91: 12238-42.
14. Chappell JD, Stuart JG. Demonstration of protection in mice from lethal challenge of three M serotypes of Streptococcus pyogenes using an M-negative vaccine. Vaccine 1993; 11: 643-8.
15. Kapur V, Maffei JT, Greer RS et al. Vaccination with streptococcal extracellular cysteine protease (interleukin-1β convertase) protects mice against challenge with heterologous group A streptococci. Microb Pathog 1994; 16: 443-50.
16. Martin RA, Silva AT, Cohen J. Effect of anti-TNF-α treatment in an antibiotic treated m urine model of shock due to Streptococcus pyogenes. FEMS Microbiol Lett 1993; 110: 175-8.
17. Wessels MR, Goldberg JB, Moses AE, DiCesare TJ. Effects of virulence of mutations in a locus essential for hydraulic acid capsule expression in group A streptococci. Infect Immun 1994; 62: 433-41.
18. Wessels MR, Moses AE, Goldberg JB, DiCesare TJ. Hyaluronic acid capsule is a virulence factor for mucoid group A streptococci. Proc Natl Acad Sci USA 1991; 88: 8317-21.
19. Whatmore AM, Kapur V, Sullivan DJ, Musser M, Kehoe M. Non-congruent relationships between variation in emm gene sequences and the population genetic structure of group A streptococci. Mol Microbiol 1994; 14: 619-31.
20. Kurl DN. Laboratory-acquired human infection with group A type 50 streptococci [letter]. Lancet 1981; 2: 752.
21. Perez-Casal J, Price JA, Maguin E, Scott JR. An M protein with a single C repeat prevents phagocytosis of Streptococcus pyogenes: use of a temperature sensitive shuttle vector to deliver homologous sequences to the chromosome of S. pyogenes. Mol Microbiol 1993; 8: 809-19.
22. Batson HC. An introduction to statistics in the medical sciences, Minneapolis, MN: Burgess Publishing Co., 1956; 62-74.
23. Stjernquist-Desatnik A, Kurl DN, Schalén C, Christensen P. Protective effect of heterologous gram-positive vaccine against lethal upper respiratory tract infection with type M50 group A streptococci in mice. Vaccine 1990; 8: 150-2.
24. Basiliere JL, Bistrong HW, Spence WF. Streptococcal pneumonia: recent outbreaks in military recruit populations. Am J Med 1968; 44: 580-9.
25. MacCallum WG. The pathology of the pneumonia in the United States Army Camps during the winter of 1917-1918. In: 'Monograph 10', Rockefeller Institute for Medical Research, 1919: 133-47.
26. McIntyre HD, Armstrong JG, Mitchell CA. Streptococcus pyogenes pneumonia with abscess formation. Aust NZ J Med. 1989; 19: 248-9.
27. McMurray JJ, Fraser DM, Brogan O. Fatal Streptococcus pyogenes pneumonia. J Royal Soc Med 1987; 80: 525-6.
28. McWhinney PHM, Nathwani D. Streptococcus group A pneumonia in an intravenous drug misuser (IVDM). Eur Respir J 1991; 4: 761-3.
29. Molteni RA. Group A β-hemolytic streptococcal pneumonia: clinical course and complications of management. Am J Dis Child 1977; 131: 1366-71.
30. Centers for Disease Control. Nursing home outbreaks of invasive group A streptococcal infections - Illinois, Kansas, North Carolina, and Texas. MMWR. 1990; 39: 577-9.
31. Harkness GA, Bentley DW, Mottley M, Lee J. Streptococcus pyogenes outbreak in a long-term care facility. Am J Inf Control 1992; 20: 142-8.
32. Martin PR, Høiby EA. Streptococcal serogroup A epidemic in Norway 1987-1988. Scand J Infect Dis 1990; 22: 421-9.
33. Schwartz B, Elliott JA, Butler JC et al. Clusters of invasive group A streptococcal infections in family, hospital, and nursing home settings. Clin Infect Dis 1992; 15: 277-84.
34. Burmeister RW, Overholt EL. Pneumonia caused by hemolytic streptococcus. Arch Int Med 1963; 111: 367-75.
35. Wildfeuer A, Heymer B, Schafer H, Haferkamp O. The cervical lymph nodes in Streptococcus pyogenes, group A, type 50, infection in mice. Med Microbiol Immunol 1978; 165: 129-37.
36. Muler KJ, Mulder JB. Ketamine and xylazine anesthesia in the mouse. Vet Med Sm Am Clin 1979; 74: 569-70.
37. Brown RC, Hopps HC. Staining of bacteria in tissue sections: a reliable gram stain method. Am J Clin Path 1973; 59: 234-40.